推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Experimental Hematology & Oncology 期刊收藏夹

2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   IF范围: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
热门AI工具: 论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重 论文摘要生成 参考文献挖掘工具 审稿意见辅助撰写
查看更多AI工具 >>
智能期刊推荐助手

推荐偏好:

 
AI写作痕迹消减工具

 

近期推荐:
全流程投稿协助套餐服务
SCI论文AI润色+人工QC服务
Springer Nature特刊征稿

按研究方向查看:


Experimental Hematology & Oncology期刊基本信息Hello,您是该期刊的第47815位访客

基本信息 登录收藏
期刊名字Experimental Hematology & OncologyExperimental Hematology & Oncology

EXP HEMATOL ONCOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.1
55人评分
我要评分

声誉
7.2

影响力
5.0

速度
7.1

期刊ISSN2162-3619
安装APP,查看期刊最新消息
iOS版下载安装安卓版下载安装
2025-2026最新IF
(数据来源于网友提供)
注册登录后,查看IF
实时影响因子 截止2026年5月06日:17.56
2025-2026自引率5.7%点击查看自引率趋势图
五年IF
(数据来源于网友提供)
14.905数据由网友[灵动幻想]收集提供
h-index 暂无h-index数据
CiteScore
2026年6月最新版
CiteScoreSJRSNIPCiteScore排名
19.604.1262.171
学科分区排名百分位
大类:Medicine
小类:Hematology
Q17 / 151
大类:Medicine
小类:Oncology
Q120 / 428
大类:Medicine
小类:Cancer Research
Q115 / 233

期刊简介
中文简介:
• 发表血液学和肿瘤学各个领域的研究
• Journal of Hematology&Oncology 的姊妹期刊
• BMC是开放获取出版先行者,推动开放透明的科研传播
Springer Nature 致力于支持研究人员推动科学进展, 通过可信赖的期刊、严谨的编辑标准以及倡导开放性、科研诚信与研究影响力的全球学术社区, 助力研究成果被广泛传播与认可。

英文简介:
• Publishes research in all areas of hematology and oncology
• The companion journal of Journal of Hematology & Oncology
• BMC is a pioneer in OA publishing, advancing open and transparent research
Springer Nature supports researchers in advancing discovery by connecting them with trusted journals, rigorous editorial standards, and a global research community committed to openness, integrity, and impact.
期刊官方网站https://link.springer.com/journal/40164
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://www.editorialmanager.com/EXHO
作者指南网址https://link.springer.com/journal/40164/collections
该期刊中国学者近期发文 - NewUnraveling the role of glutamine metabolism in cancer: from cell death mechanisms to tumor microenvironment modulation
Author: Peng, Xintong; Liu, Shuang; Tao, Yongguang
Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00812-1


Sequential therapy with decitabine and an XPO-1 inhibitor followed by allogeneic hematopoietic stem cell transplantation in MDS with biallelic TP53 inactivation patients : a preliminary case series
Author: Ren, Yanling; Lang, Wei; Xu, Yu; Mei, Chen; Huang, Xianbo; Wang, Shasha; Qian, Jiejing; Tong, Hongyan
Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00817-w


AAV-delivered miRNA-gated Cre circuits enable programmable gene activation in AFP-active liver tumor models
Author: Zhang, Xiaoting; Cao, Congcong; Huang, Zeqi; Wu, Dongde; Yin, Tao; Liu, Yuchen; Shen, Jian; Li, Aolin; Yang, Shuofei; Nie, Lei
Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00814-z


Arsenic trioxide promotes a glue-like interaction to drive STUB1-mediated NPM-ALK degradation in ALK+ ALCL
Author: Li, Guiming; Wang, Jun; Ye, Shiguang; Zhou, Lixin; Sun, Yanli; Li, Bowen; Zhao, Yunshuo; Ding, Yi; Zeng, Yu; Xue, Bin; Wang, Guangming; Wang, Fangce; Luo, Xiu; Liang, Aibin; Weisberg, Ellen L.; Zhang, Wenjun; Lu, Wenchao; Yang, Jing
Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00800-5


期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Experimental Hematology & Oncology的语言要求,还能让Experimental Hematology & Oncology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Experimental Hematology & Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(1篇)
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( GBP2490; USD3190; EUR2790; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:haematology、oncology
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
出版商BioMed Central
涉及的研究方向Medicine-Oncology
出版国家或地区ENGLAND
出版语言English
出版周期
出版年份2012
年文章数 92点击查看年文章数趋势图
Gold OA文章占比100.00%
研究类文章占比:
文章 ÷(文章 + 综述)
63.04%
WOS期刊JCR分区
2025-2026年最新版
注册登录后,查看WOS分区等级
期刊分区表预警名单 2026年03月发布的新锐学术版:不在预警名单中

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
《新锐期刊分区表》
2026年3月发布
点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 1区1区2区
ONCOLOGY
肿瘤学
2区2区1区
HEMATOLOGY
血液学
3区3区1区
N/A
期刊分区表
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学 4区2区2区
HEMATOLOGY
血液学
1区4区2区
ONCOLOGY
肿瘤学
1区2区2区
期刊分区表
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区1区4区
HEMATOLOGY
血液学
2区2区2区
ONCOLOGY
肿瘤学
2区3区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2162-3619%5BISSN%5D
平均审稿速度网友分享经验:
6 Weeks
平均录用比例网友分享经验:
版面费/APC文章处理费信息
文章处理费:需要( GBP2490; USD3190; EUR2790; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Experimental Hematology & Oncology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(1篇)
提交文稿
期刊常用信息链接
同领域相关期刊 Experimental Hematology & Oncology期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Experimental Hematology & Oncology期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Experimental Hematology & Oncology上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Nature Cancer038.50
    JAMA Oncology6132.60
    JAMA Oncology4132.60
    Trends in Cancer030.80
    Cancer Biology & Medicine2911.50
    ESMO Open012.00
    Liver Cancer2517.00
    Cancer Pathogenesis and Therapy06.20
    Annual Review of Cancer Biology010.00
    JNCI Cancer Spectrum06.00
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE920629
    JOURNAL OF ETHNOPHARMACOLOGY821609
    Frontiers in Immunology772811
    BIOMEDICINE & PHARMACOTHERAPY740890
    Frontiers in Pharmacology737108
    BIOMATERIALS729353
    PHYTOMEDICINE666104
    Frontiers in Oncology635758
    Biomedical Signal Processing and Control624708
    IEEE Journal of Biomedical and Health Informatics617106
  •  

    Experimental Hematology & Oncology Experimental Hematology & Oncology
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Unraveling the role of glutamine metabolism in cancer: from cell death mechanisms to tumor microenvironment modulation

    Author: Peng, Xintong; Liu, Shuang; Tao, Yongguang
    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00812-1
        DOI
    2.Sequential therapy with decitabine and an XPO-1 inhibitor followed by allogeneic hematopoietic stem cell transplantation in MDS with biallelic TP53 inactivation patients : a preliminary case series

    Author: Ren, Yanling; Lang, Wei; Xu, Yu; Mei, Chen; Huang, Xianbo; Wang, Shasha; Qian, Jiejing; Tong, Hongyan
    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00817-w
        DOI
    3.AAV-delivered miRNA-gated Cre circuits enable programmable gene activation in AFP-active liver tumor models

    Author: Zhang, Xiaoting; Cao, Congcong; Huang, Zeqi; Wu, Dongde; Yin, Tao; Liu, Yuchen; Shen, Jian; Li, Aolin; Yang, Shuofei; Nie, Lei
    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00814-z
        DOI
    4.Arsenic trioxide promotes a glue-like interaction to drive STUB1-mediated NPM-ALK degradation in ALK+ ALCL

    Author: Li, Guiming; Wang, Jun; Ye, Shiguang; Zhou, Lixin; Sun, Yanli; Li, Bowen; Zhao, Yunshuo; Ding, Yi; Zeng, Yu; Xue, Bin; Wang, Guangming; Wang, Fangce; Luo, Xiu; Liang, Aibin; Weisberg, Ellen L.; Zhang, Wenjun; Lu, Wenchao; Yang, Jing
    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00800-5
        PubMed      DOI
    5.Emerging venetoclax plus hypomethylating agent-based triplet regimens in newly diagnosed acute myeloid leukemia: updates from the 2025 ASH Annual Meeting

    Author: Yu, Haibo; Shi, Ting; Zhu, Hong-Hu
    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00810-3
        PubMed      DOI
    6.Frontline T cell-redirecting therapies in newly diagnosed multiple myeloma: key signals from the 2025 ASH Annual Meeting

    Author: Zhou, Huixing; Jin, Xiaoyun; Chen, Wenming; Zhu, Hong-Hu; Gao, Wen
    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00809-w
        PubMed      DOI
    7.Optimizing the timing of JAK1 inhibition preserves the anti-tumor efficacy of radioimmunotherapy in lung cancer by preventing T cell exhaustion

    Author: Gao, Zhiru; Yang, Linlin; Wang, Linlin
    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00802-3
        PubMed      DOI
    8.Autologous transplant versus matched sibling donor transplant in intermediate-risk AML in CR1 with no detectable MRD: a biological assignment comparative study

    Author: Yu, Sijian; Liu, Hui; Zhao, Weihua; Yu, Guopan; Shi, Pengcheng; Nie, Danian; Sun, Zhiqiang; Liu, Qianwei; Shao, Ruoyang; Feng, Zinan; Liang, Xinquan; Zhang, Xiong; Du, Xin; Xu, Xiaojun; Wang, Shunqing; Zhang, Qing; Jiang, Yirong; Zhang, Hongyu; Guo, Ziwen; Dai, Min; Jiang, Xuejie; Xu, Dan; Huang, Fen; Fan, Zhiping; Xu, Na; Liu, Qiong; Liang, Qianyi; Liu, Can; Wu, Meiqing; Weng, Guangyang; Lin, Ren; Jin, Hua; Sun, Jing; Wang, Yu; Xuan, Li; Zhang, Yu; Liu, Qifa
    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00807-y
        PubMed      DOI
    9.Role of methionine metabolism in cancer: recent advances in molecular mechanisms and therapeutic implications

    Author: Yang, Pei-wen; Xu, Xin-yi; Jiao, Ju-ying; Wang, Feng-jiao; Chen, Zhen
    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00806-z
        PubMed      DOI
    10.MAGEC2 promotes tumorigenesis in multiple myeloma through USP16-mediated deubiquitination and stabilization of c-Myc

    Author: Liu, Zihao; Hu, Tingting; Min, Jie; Wang, Chen; Cao, Yuhao; Guo, Mengjie; Qian, Jinjun; Gu, Chunyan; Yang, Ye
    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00782-4
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    LANCET70092.40
    MMWR Surveillance Summaries093.20
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
    Nature Reviews Disease Primers4871.30
    World Psychiatry6184.80
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386165.20
    LANCET70092.40
    NATURE REVIEWS MICROBIOLOGY250124.00
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Nature Reviews Materials61110.60
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共5


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室